Last reviewed · How we verify
NCT04069507: HHS
Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
trial in Femoroacetabular Impingement in 88 participants. Completed in 22 September 2024.
22 September 2023
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 88 |
| Start date | 15 October 2019 |
| Primary completion | 22 September 2023 |
| Estimated completion | 22 September 2024 |
| Sites | 1 location across United States |
Conditions studied
- Femoroacetabular Impingement — all drugs for Femoroacetabular Impingement →
- Acetabular Dysplasia — all drugs for Acetabular Dysplasia →
- Acetabular Labrum Tear — all drugs for Acetabular Labrum Tear →
- Hip Pain — all drugs for Hip Pain →
Sponsor
Washington University School of Medicine
Who can join
Adults 15 to 40, any sex, with Femoroacetabular Impingement or Acetabular Dysplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pre-arthritic hip disorders can cause pain, interfere with daily activities and exercise, and lead to the development of osteoarthritis in young adults. Surgical and conservative treatment options are being developed and studied, but it is currently unclear why some patients improve with a particular treatment plan while others do not. The goal of this research project is to develop a tool that predicts which combination of treatment options will be most effective for each individual patient.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Patients' real-world engagement with movement pattern modifications for nonarthritic hip-related pain.
Cheng AL, Hannemann AJ, Brady BK, Pashos MM, et al · · 2025 · cited 2× · PMID 39953925 · DOI 10.1002/pmrj.13343 -
Predictors and rate of satisfactory response to nonoperative management for nonarthritic hip-related pain.
Cheng AL, Pashos MM, Hannemann AJ, Brady BK, et al · · 2026 · PMID 41589432 · DOI 10.1002/pmrj.70085 -
Defining the Minimal Clinically Important Improvement, Substantial Clinical Benefit, and Patient Acceptable Symptom State for the iHOT-12, HOOS, and HOOS<sub>global</sub> in the Nonoperative Management of Nonarthritic Hip-Related Pain.
Cheng AL, Radlicz CM, Pashos MM, Huecker JB, et al · · 2025 · PMID 40123108 · DOI 10.1177/03635465251325466
Verify or expand the search:
- PubMed search for NCT04069507
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Femoroacetabular Impingement
Currently open trials in the same condition.
- NCT06272292 — Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls · NA · recruiting
- NCT06536088 — The Relationship Between Gait and Severity of Femoroacetabular Impingement · recruiting
- NCT05025956 — Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan · Phase 1, PHASE2 · active not recruiting
- NCT03891563 — Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip · active not recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04069507 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 28 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04069507.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing